22 results

209 Immune dysregulation in extranodal NK/T cell lymphomas: potential roles in pathogenesis and immunotherapy
Chantana Polprasert, Kitsada Wudhikarn, Ponlapat Rojnuckarin
KMSID: 1148616   Blood Res. 2021;56(4):209-211.   Published online 2021 December 31    DOI: http://dx.doi.org/10.5045/br.2021.2021123
      
212 Subclinical thrombotic thrombocytopenic purpura after vaccination with ChAdOx1 nCoV-19
Hee Ryeong Jang, Kyu-Hyoung Lim
KMSID: 1148617   Blood Res. 2021;56(4):212-214.   Published online 2021 December 31    DOI: http://dx.doi.org/10.5045/br.2021.2021140
      
215 Effects and treatment applications of polymeric nanoparticles on improving platelets’ storage time: a review of the literature from 2010 to 2020
Tahereh Zadeh Mehrizi, Sedigheh Amini Kafiabad, Peyman Eshghi
KMSID: 1148619   Blood Res. 2021;56(4):215-228.   Published online 2021 December 31    DOI: http://dx.doi.org/10.5045/br.2021.2021094
      
229 A narrative review on adverse effects of dasatinib with a focus on pharmacotherapy of dasatinib-induced pulmonary toxicities
Zahra Nekoukar, Minoo Moghimi, Ebrahim Salehifar
KMSID: 1148618   Blood Res. 2021;56(4):229-242.   Published online 2021 December 31    DOI: http://dx.doi.org/10.5045/br.2021.2021117
      
243 Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in Korea
Jun Ho Yi, Gyeong-Won Lee, Ji Hyun Lee, Kwai Han Yoo, Chul Won Jung, Dae Sik Kim, Jeong-Ok Lee, Hyeon Seok Eom, Ja Min Byun, Youngil Koh, Sung Soo Yoon, Jin Seok Kim, Jee Hyun Kong, Ho-Young Yhim, Deok-Hwan Yang, Dok Hyun Yoon, Do Hyoung Lim, Won-Sik Lee, Ho-Jin Shin
KMSID: 1148620   Blood Res. 2021;56(4):243-251.   Published online 2021 December 31    DOI: http://dx.doi.org/10.5045/br.2021.2021102
      
252 Mutation analysis and characterisation of F9 gene in haemophilia-B population of India
Sujayendra Kulkarni, Rajat Hegde, Smita Hegde, Suyamindra S. Kulkarni, Suresh Hanagvadi, Kusal K. Das, Sanjeev Kolagi, Pramod B. Gai, Rudragouda Bulagouda
KMSID: 1148621   Blood Res. 2021;56(4):252-258.   Published online 2021 December 31    DOI: http://dx.doi.org/10.5045/br.2021.2021016
      
259 Clinical features and outcomes of JAK2 V617F-positive polycythemia vera and essential thrombocythemia according to the JAK2 V617F allele burden
A-Jin Lee, Sang-Gyung Kim, Jun Yeb Nam, Jaehum Yun, Hun-Mo Ryoo, Sung Hwa Bae
KMSID: 1148622   Blood Res. 2021;56(4):259-265.   Published online 2021 December 31    DOI: http://dx.doi.org/10.5045/br.2021.2021089
      
266 Outcomes of bortezomib combination chemotherapies in autologous stem cell transplantation-ineligible patients with AL amyloidosis
Joon Young Hur, Sang Eun Yoon, Darae Kim, Jin-oh Choi, Ju-Hong Min, Byung Jun Kim, Jung Sun Kim, Jung Eun Lee, Joon Young Choi, Eun-Seok Jeon, Seok Jin Kim, Kihyun Kim
KMSID: 1148623   Blood Res. 2021;56(4):266-278.   Published online 2021 December 31    DOI: http://dx.doi.org/10.5045/br.2021.2021121
      
279 Treatment of adult Burkitt lymphoma with the CALGB 1002 protocol: a single center experience in Jordan
Mohammad Ma’koseh, Rula Amarin, Faris Tamimi, Baha’ Sharaf, Alaa Abufara, Omar Shahin, Mohammed K. M. Manassra, Khalid Halahleh
KMSID: 1148624   Blood Res. 2021;56(4):279-284.   Published online 2021 December 31    DOI: http://dx.doi.org/10.5045/br.2021.2021116
      
285 R-MPV followed by high-dose chemotherapy with thiotepa-based and autologous stem cell transplantation for newly diagnosed primary central nervous system lymphoma: a single-center experience
Ji Yun Lee, Jin Ho Paik, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong-Seok Lee, Jeong-Ok Lee
KMSID: 1148625   Blood Res. 2021;56(4):285-292.   Published online 2021 December 31    DOI: http://dx.doi.org/10.5045/br.2021.2021073
      
293 The demographic, clinical, and medical manifestations of pulmonary thromboembolism development in COVID-19
Somayeh Sadeghi, Maryam Nasirian, Elaheh Keivany, Peiman Nasri, Maryam Sadat Mirenayat
KMSID: 1148626   Blood Res. 2021;56(4):293-300.   Published online 2021 December 31    DOI: http://dx.doi.org/10.5045/br.2021.2021131
      
301 Twenty-year incidence trend of hematologic malignancies in the Republic of Korea: 1999‒2018
Won-Ju Park, Joo-Heon Park, Seunghyeon Cho, Myung Geun Shin
KMSID: 1148627   Blood Res. 2021;56(4):301-314.   Published online 2021 December 31    DOI: http://dx.doi.org/10.5045/br.2021.2021187
      
315 Blood management strategies in congenital Glanzmann thrombasthenia at a hematology referral center
Ganesh Kasinathan, Jameela Sathar
KMSID: 1148628   Blood Res. 2021;56(4):315-321.   Published online 2021 December 31    DOI: http://dx.doi.org/10.5045/br.2021.2021165
      
322 Real-life ruxolitinib experience in intermediate-risk myelofibrosis
Fatma Arikan, Tayfur Toptas, Isik Kaygusuz Atagunduz, Tarik Ercan, Ozen Oruc, Fergun Yilmaz, Tulin Tuglular
KMSID: 1148629   Blood Res. 2021;56(4):322-331.   Published online 2021 December 31    DOI: http://dx.doi.org/10.5045/br.2021.2021101
      
332 Shared molecular basis, diagnosis, and co-inheritance of alpha and beta thalassemia
Govinda Khatri, Abdul Moiz Sahito, Saboor Ahmed Ansari
KMSID: 1148630   Blood Res. 2021;56(4):332-333.   Published online 2021 December 31    DOI: http://dx.doi.org/10.5045/br.2021.2021128
      
333 Tp53 disruptions: is there a marker of poor prognosis in chronic lymphoproliferative disorders?
Emanuele Cencini, Alberto Fabbri, Donatella Raspadori, Alessandro Gozzetti, Monica Bocchia
KMSID: 1148631   Blood Res. 2021;56(4):333-334.   Published online 2021 December 31    DOI: http://dx.doi.org/10.5045/br.2021.2020322
      
335 A look inside the body of a BCR-ABL1−like acute lymphoblastic leukemia patient: the first case report highlighting the continued relevance of autopsy practice
Pulkit Rastogi, Prateek Bhatia, Sreejesh Sreedharanunni, Deepesh Lad
KMSID: 1148632   Blood Res. 2021;56(4):335-339.   Published online 2021 December 31    DOI: http://dx.doi.org/10.5045/br.2021.2020231
      
339 Therapy-related acute myeloid leukemia in a patient with B-cell acute lymphoblastic leukemia
Smeeta Gajendra, Akshay Ramesh Gore, Bhawna Jha, Nitin Sood, Manorama Bhargava
KMSID: 1148633   Blood Res. 2021;56(4):339-342.   Published online 2021 December 31    DOI: http://dx.doi.org/10.5045/br.2021.2021093
      
342 Efficacy of ponatinib prior to and after allogeneic hematopoietic stem cell transplantation in an adolescent with chronic myeloid leukemia in blast phase
Jae Wook Lee, Jae Won Yoo, Seongkoo Kim, Pil-Sang Jang, Nack-Gyun Chung, Bin Cho
KMSID: 1148634   Blood Res. 2021;56(4):342-345.   Published online 2021 December 31    DOI: http://dx.doi.org/10.5045/br.2021.2021104
      
345 A case of e1a2 (minor, P190) BCR-ABL1-positive chronic myeloid leukemia in Korea
Yu Jeong Choi, Ja Yoon Heo, Jongha Yoo
KMSID: 1148635   Blood Res. 2021;56(4):345-347.   Published online 2021 December 31    DOI: http://dx.doi.org/10.5045/br.2021.2020331
      
347 Immune thrombocytopenic purpura worsened by COVID-19
Chul Soo Kim, Dae Ro Choi, Jong Hwa Lee
KMSID: 1148636   Blood Res. 2021;56(4):347-349.   Published online 2021 December 31    DOI: http://dx.doi.org/10.5045/br.2021.2021147
      
349 Therapy-related myeloid neoplasms after transcatheter arterial chemoembolization for hepatocellular carcinoma
Jun Ho Yi, Jun Ho Jang, Chul Won Jung
KMSID: 1148637   Blood Res. 2021;56(4):349-353.   Published online 2021 December 31    DOI: http://dx.doi.org/10.5045/br.2021.2021197
      
Articles from Blood Research are provided here courtesy of Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of